Shares of Iovance Biotherapeutics reached a new 52-week high, hitting $6.94 USD.
Market participants noted the movement as the equity climbed to its highest level over the past year.
Iovance Biotherapeutics stock touched a new 52-week high during recent trading sessions.

Shares of Iovance Biotherapeutics reached a new 52-week high, hitting $6.94 USD.
Market participants noted the movement as the equity climbed to its highest level over the past year.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →

